Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 14B (LRRC14B) is a protein-coding gene product belonging to the large family of leucine-rich repeat proteins, characterized by tandem repeats rich in the amino acid leucine[1][5]. It is classified as a member of the PRAME family and is expressed in a broad range of human tissues, with particularly broad but low-level tissue distribution[3][6]. There is insufficient evidence that LRRC14B is a direct therapeutic target, receptor, enzyme, or component of major signaling pathways, and its specific molecular function and role in pathophysiology remain unknown[1][5]. Mouse orthologs exist, suggesting a conserved but not well-characterized biological role[4][7]. LRRC14B is *not* considered a canonical therapeutic target (such as a receptor, enzyme, or transporter), nor are any interacting drugs or mechanisms currently described in the literature or key biological databases[1][5]. Available data confirm its classification as a leucine-rich repeat protein with unknown function and limited disease association[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 14B (LRRC14B).